by
Gus Iversen, Editor in Chief | June 30, 2016
HCB News: Is Riverwoods involved in any research studies?
WG: Yes.
Ad Statistics
Times Displayed: 19946
Times Visited: 374 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
HCB News: Can you comment on any of them?
WG: Well, we’re currently running a study looking at technology to improve the data fidelity of fMRI using a cubic interpolation method from Novarad which gives us about a 25 percent signal for the noise or improvement in data fidelity of the T tests. So that’s a huge step. That’s almost like, um, doubling the acquisition, uh the number of acquisitions. We are doing a normative control study looking at six different neuropsychological tests as well as resting state to provide a control data base for certain techniques. And we are pursuing a study of athletes before they are injured. You know, looking at high risk athletes, certain types of football players, etc. Soccer players. And scanning them at the beginning of their collegiate career and then doing a forward longitudinal study of how they, uh, you know, if they have a concussion then we have a base line to compare with.
HCB News: In five years what will people be talking about with regards to fMRI?
WG: I think that you’ll see much more chronical utilization of this. I think that you’ll see a lot more neurosurgeons, neurologists, and other health care professionals requesting the studies. I think neuroradiologists will have to be a lot more involved in this. They’re going to have to learn a lot more of the neuro anatomy and some of the pitfalls. I think it will become much more like PET scanning where it’s actively used in the clinical arena. And I think there will be far more standardization, better data bases of what normal controls are. And so we’ll have a better feel for how to use this clinically.
About Dr. Gibby
Dr. Wendell Gibby is a board-certified diagnostic radiologist with a subspecialty in neuroradiology. Dr. Gibby founded Novarad in 1990, in order to create a solution that focused on radiologists.
He currently owns and operates multi-modality imaging centers in Provo, Utah and Salt Lake City, Utah. He served for 18 years at Utah Regional Medical Center and with Utah Valley Radiology Associates. He is currently Associate Professor of Clinical Radiology at the University of Arizona Medical School and lectures frequently at radiology association meetings.Back to HCB News
